Zimmer Biomet's $2.08 Billion Q2 Sales Ignite Orthopedic Surge, Boosts Guidance Outlook
1. ZBH reported Q2 adjusted earnings of $2.07 per share, exceeding estimates. 2. Sales increased 7%, reaching $2.08 billion, beating consensus expectations. 3. Guidance for 2025 adjusted earnings raised to $8.10-$8.30 per share. 4. Hip and knee product sales showed notable growth, enhancing overall revenue. 5. Adjusted gross margin improved to 72.3%, indicating operational efficiency.